Tag: Clinical research
BioVoice eMag December 2016 – January 2017 Issue-8 Volume-1
BioVoice eMag December 2016 - January 2017 Issue-8 Volume-1:
This edition of BioVoice features detailed cover story on demonetization move and the immediate steps taken...
BioVoice eMag October 2016 Issue-6 Volume-1
BioVoice eMag October 2016 Issue-6 Volume-1:
The October edition of BioVoice features detailed cover story on relevance of biotechnology sector in India. Besides an analysis...
Top experts discuss pharmacovigilant environment in India
Deliberations at the symposium organized by Indian Society for Clinical Research included the evolving regulatory environment in India with focus...
World Alzheimer’s Day: Cure evades 4 million Indian patients!
This September 21st on World Alzheimer’s Day, Indian Society for Clinical Research (ISCR) highlighted the need for acceleration of clinical research for dementia....
CDSA partners with Acceliant to accelerate clinical research & new drug...
CDSA will leverage Acceliant's robust solutions for its clinical trials that run under the various.....
Applications for grant of NOCs for BA/BE studies made ‘online only’...
As a part of its e-governance initiatives, the clinical research regulator will accept only online application from 13 September 2016 for issue of NOCs.....
On its way back to revival, Indian clinical research industry awaits...
There used to be a time when India was an instant hit globally for its affordable yet quality expertize in handling clinical trials but then.....
Quintiles, DaVita Clinical Research enter into strategic alliance
DaVita Clinical Research brings to this alliance data-driven trial feasibility expertise, trial sites in Europe and Latin America, its deep.....
Industry welcomes CDSCO’s circular on investigators & sites
The Central Drugs Standard Control Organization's decision reflects the views of most of the stakeholders, mentioned the Indian Society for.......
Quintiles welcomes DCGI’s revised rules on clinical trials
In a statement, one of the leading global players in clinical research has appreciated the move by the Drugs Controller General.....